Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14

Oncogene

Volumn 32, Issue 16, 2013, Pages 2087-2095

  Zhang, P ^a   Guo, A ^b   Possemato, A ^b   Wang, C ^a   Beard, L ^a   Carlin, C ^a   Markowitz, S D ^a   Polakiewicz, R D ^b   Wang, Z ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CELL SIGNALING TECHNOLOGY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

colorectal cancer; p130Cas; PTPN14; tumorigenesis

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; DASATINIB; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 14; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CARCINOGENICITY; CELL MIGRATION; CELL SPREADING; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CRK-ASSOCIATED SUBSTRATE PROTEIN; EPIDERMAL GROWTH FACTOR; FEMALE; GENE KNOCK-IN TECHNIQUES; HCT116 CELLS; HEK293 CELLS; HT29 CELLS; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; PYRIMIDINES; SIGNAL TRANSDUCTION; THIAZOLES; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 84876694091     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.220     Document Type: Article

References (43)

1. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411: 355-365.
2. Brognard J, Hunter T. Protein kinase signaling networks in cancer. Curr Opin Genet Dev 2011; 21: 4-11.
3. Julien SG, Dubé N, Hardy S, Tremblay ML. Inside the human cancer tyrosine phosphatome. Nat Rev Cancer 2011; 11: 35-49.
4. Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004; 304: 1164-1166.
5. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615.
6. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268-274.
7. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-1160.
8. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828-829.
9. van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009; 41: 521-523.
10. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 2011; 43: 442-446.
11. Wyatt L, Khew-Goodall Y. PTP-Pez: a novel regulator of TGFbeta signaling. Cell Cycle 2008; 7: 2290-2295.
12. Wadham C, Gamble JR, Vadas MA, Khew-Goodall Y. The protein tyrosine phos-phatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. Mol Biol Cell 2003; 14: 2520-2529.
13. Ogata M, Takada T, Mori Y, Oh-hora M, Uchida Y, Kosugi A et al. Effects of overexpression of PTP36, a putative protein tyrosine phosphatase, on cell adhesion, cell growth, and cytoskeletons in HeLa cells. J Biol Chem 1999; 274: 12905-12909.
14. Wadham C, Gamble JR, Vadas MA, Khew-Goodall Y. Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the nucleus is associated with induction of cell proliferation. J Cell Sci 2000; 113(Pt 17): 3117-3123.
15. Wyatt L, Wadham C, Crocker LA, Lardelli M, Khew-Goodall Y. The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-mesenchymal transition, and organ development. J Cell Biol 2007; 178: 1223-1235.
16. Reynolds AB, Kanner SB, Wang HC, Parsons JT. Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins. Mol Cell Biol 1989; 9: 3951-3958.
17. Matsuda M, Mayer BJ, Fukui Y, Hanafusa H. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 1990; 248: 1537-1539.
18. Dorssers LC, van Agthoven T, Dekker A, van Agthoven TL, Kok EM. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site. Mol Endocrinol 1993; 7: 870-878.
19. Cabodi S, Tinnirello A, Di Stefano P, Bisaro B, Ambrosino E, Castellano I et al. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006; 66: 4672-4680.
20. Burnham MR, Harte MT, Richardson A, Parsons JT, Bouton AH. The identification of p130cas-binding proteins and their role in cellular transformation. Oncogene 1996; 12: 2467-2472.
21. Honda H, Oda H, Nakamoto T, Honda Z, Sakai R, Suzuki T et al. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 1998; 19: 361-365.
22. Defilippi P, Di Stefano P, Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 2006; 16: 257-263.
23. Flint AJ, Tiganis T, Barford D, Tonks NK. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 1997; 94: 1680-1685.
24. Blanchetot C, Chagnon M, Dube N, Halle M, Tremblay ML. Substrate-trapping techniques in the identification of cellular PTP targets. Methods 2005; 35: 44-53.
25. Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 2005; 23: 94-101.
26. Zhang X, Guo C, Chen Y, Shulha HP, Schnetz MP, LaFramboise T et al. Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies. Nat Methods 2008; 5: 163-165.
27. Montero JC, Seoane S, Ocana A, Pandiella A. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clin Cancer Res 2011; 17: 5546-5552.
28. Yarom N, Jonker DJ. The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer. Discov Med 2011; 11: 95-105.
29. Hirata R, Chamberlain J, Dong R, Russell DW. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol 2002; 20: 735-738.
30. Kohli M, Rago C, Lengauer C, Kinzler KW, Vogelstein B. Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res 2004; 32: e3.
31. Du Z, Song J, Wang Y, Zhao Y, Guda K, Yang S et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 2010; 3: ra80.
32. Avraham R, Yarden Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 2011; 12: 104-117.
33. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005; 5: 921-929.
34. Bohnacker T, Marone R, Collmann E, Calvez R, Hirsch E, Wymann MP. PI3K{-gamma} Adaptor Subunits Define Coupling to Degranulation and Cell Motility by Distinct PtdIns(3, 4, 5)P3 Pools in Mast Cells. Sci Signal 2009; 2: ra27.
35. 0-kinase in v-crk-transformed cells. Mol Cancer Res 2003; 1: 428-437.
36. Li E, Stupack DG, Brown SL, Klemke R, Schlaepfer DD, Nemerow GR. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 2000; 275: 14729-14735.
37. Goldberg GS, Alexander DB, Pellicena P, Zhang ZY, Tsuda H, Miller WT. Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells. J Biol Chem 2003; 278: 46533-46540.
38. Patwardhan P, Shen Y, Goldberg GS, Miller WT. Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth. J Biol Chem 2006; 281: 20689-20697.
39. Akagi T, Murata K, Shishido T, Hanafusa H. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Mol Cell Biol 2002; 22: 7015-7023.
40. Liang F, Kumar S, Zhang ZY. Proteomic approaches to studying protein tyrosine phosphatases. Mol Biosyst 2007; 3: 308-316.
41. Zhang X, Guo A, Yu J, Possemato A, Chen Y, Zheng W et al. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. PNAS 2007; 104: 4060-4064.
42. Zhao Y, Zhang X, Guda K, Lawrence E, Sun Q, Watanabe T et al. Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proc Natl Acad Sci USA 2010; 107: 2592-2597.
43. Zhang P, Zhao Y, Zhu X, Sedwick D, Zhang X, Wang Z. Cross-talk between phospho-STAT3 and PLC{gamma}1 plays a critical role in colorectal tumorigenesis. Mol Cancer Res 2011; 9: 1418-1428.